Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00374764 · ClinicalTrials.gov registry record · NA
Comparison of Applied Behavioral Analysis (ABA) Versus ABA and Risperidone
A NA study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT00374764 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 60 participants.
The verdict
NCT00374764, a NA study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
Hypotheses: 1. Preschool children with autism spectrum disorders (ASDs) who undergo ABA treatment only will demonstrate significantly better outcomes compared to an age and severity matched control group without ABA treatment. 2. Preschool children with ASDs who undergo ABA in combination with risperidone will demonstrate significantly better outcomes compared to age and severity matched children who are receiving ABA alone. 3. Young age, cognitive development and attentional abilities at baseline will be predictive of good socio-emotional and neuropsychological outcomes after ABA treatment. 4. At baseline, children with ASDs will show significantly lower performances on measures of cognitive, neuropsychological, and socio-emotional functioning than age-matched typically developing controls.
Interventions
- DRUG Risperidone
- BEHAVIORAL ABA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2000-07 |
| Est. Completion | 2002-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00374764
The ClinicalTrials.gov registry entry for NCT00374764 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Risperidone is the first listed.
NCT00374764 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00374764 about?
NCT00374764 is a clinical study titled "Comparison of Applied Behavioral Analysis (ABA) Versus ABA and Risperidone". Hypotheses: 1. Preschool children with autism spectrum disorders (ASDs) who undergo ABA treatment only will demonstrate significantly better outcomes compared to an age and severity matched control group without ABA treatment. 2. Preschool children with ASDs who undergo ABA in combination with risp...
What is the current status of trial NCT00374764?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2000-07. Estimated completion is 2002-06.
What interventions are being tested in trial NCT00374764?
The interventions under investigation include: Risperidone (DRUG), ABA (BEHAVIORAL).
Who is sponsoring clinical trial NCT00374764?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.